Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.85B |
| 2 |
Linde
LIN
|
+$1.14B |
| 3 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$653M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$629M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$591M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortive
FTV
|
+$1.17B |
| 2 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$981M |
| 3 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$416M |
| 4 |
Amazon
AMZN
|
+$402M |
| 5 |
State Street Industrial Select Sector SPDR ETF
XLI
|
+$338M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 6.9% |
| 2 | Healthcare | 5.31% |
| 3 | Financials | 5.25% |
| 4 | Communication Services | 4.61% |
| 5 | Consumer Discretionary | 4.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5351
PUT
Flex
FLEX
$45B
| $52K | ﹤0.01% |
9,024
-12,872
| -59% | -$89.9K |
|
|
GLDD
5352
DELISTED
Great Lakes Dredge & Dock
GLDD
| $52K | ﹤0.01% |
7,886
-55,924
| -88% | -$365K |
|
5353
PUT
Global Payments
GPN
$22.9B
| $52K | ﹤0.01% |
+500
| New | +$55.1K |
|
5354
Immersion
IMMR
$254M
| $52K | ﹤0.01% |
5,893
-17,940
| -75% | -$168K |
|
5355
PUT
Macerich
MAC
$6.88B
| $52K | ﹤0.01% |
1,200
+200
| +20% | +$9.89K |
|
5356
Syndax Pharmaceuticals
SNDX
$1.81B
| $52K | ﹤0.01% |
11,852
-6,081
| -34% | -$33.3K |
|
5357
TFS Financial
TFSL
$4.82B
| $52K | ﹤0.01% |
3,266
-1,410
| -30% | -$21.6K |
|
|
RRD
5358
PUT
DELISTED
RR Donnelley & Sons Co.
RRD
| $52K | ﹤0.01% |
13,100
+6,600
| +102% | +$34.3K |
|
5359
PUT
BJ's Restaurants
BJRI
$1.46B
| $51K | ﹤0.01% |
+1,000
| New | +$60.3K |
|
|
EXK
5360
CALL
Endeavour Silver
EXK
$3.08B
| $51K | ﹤0.01% |
23,600
-6,800
| -22% | -$14.3K |
|
5361
Goldgroup Mining Inc.
GORO
$185M
| $51K | ﹤0.01% |
12,644
-41,412
| -77% | -$187K |
|
5362
State Street SPDR S&P China ETF
GXC
$478M
| $51K | ﹤0.01% |
603
+476
| +375% | +$42.3K |
|
5363
ProQR Therapeutics
PRQR
$265M
| $51K | ﹤0.01% |
+3,216
| New | +$59K |
|
|
ANAT
5364
DELISTED
American National Group, Inc. Common Stock
ANAT
| $51K | ﹤0.01% |
401
-1,446
| -78% | -$180K |
|
|
ACHN
5365
DELISTED
Achillion Pharmaceuticals
ACHN
| $51K | ﹤0.01% |
32,709
-84,694
| -72% | -$239K |
|
5366
Bloom Energy
BE
$62.4B
| $50K | ﹤0.01% |
4,965
+4,865
| +4,865% | +$94K |
|
5367
PUT
Darling Ingredients
DAR
$9.99B
| $50K | ﹤0.01% |
+2,600
| New | +$52.7K |
|
|
HEPA
5368
DELISTED
Hepion Pharmaceuticals
HEPA
| $50K | ﹤0.01% |
3
+2
| +200% | +$68.6K |
|
5369
iRadimed
IRMD
$1.14B
| $50K | ﹤0.01% |
2,059
+721
| +54% | +$19.4K |
|
|
NGD
5370
DELISTED
New Gold Inc
NGD
| $50K | ﹤0.01% |
65,947
+26,769
| +68% | +$21.6K |
|
|
HTT
5371
CALL
High Templar Tech Ltd
HTT
$387M
| $50K | ﹤0.01% |
11,700
+700
| +6% | +$3.34K |
|
5372
Telecom Argentina
TEO
$5.99B
| $50K | ﹤0.01% |
3,189
-1,610
| -34% | -$27.6K |
|
|
TECX
5373
Tectonic Therapeutic
TECX
$629M
| $50K | ﹤0.01% |
251
-40
| -14% | -$12.2K |
|
|
NWLI
5374
DELISTED
National Western Life Group, Inc. Class A
NWLI
| $50K | ﹤0.01% |
166
-780
| -82% | -$228K |
|
|
AAIC
5375
DELISTED
Arlington Asset Investment Corp.
AAIC
| $50K | ﹤0.01% |
6,959
-4,306
| -38% | -$36.2K |
|
Similar funds
Barclays's Q4 2018 Portfolio in Review
As of Q4 2018, Barclays held 7,834 positions worth $129B, down 10% from $144B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Barclays deployed $5.69B of net new capital in Q4 2018, opening 489 new positions and adding to 2,471 existing holdings. Its largest new stake was Linde: 7,232,686 shares worth $1.13B.
By sector, the portfolio is most concentrated in Technology at 6.9% of assets, down from 8.2% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Fortive, an estimated $1.17B trimmed.
- Barclays's largest Q4 2018 buy was Linde: 7,232,686 shares worth $1.13B.
- Barclays added most to State Street SPDR S&P 500 ETF Trust in Q4 2018, an estimated $1.85B increase.
- Barclays's biggest Q4 2018 reduction was Fortive, cutting an estimated $1.17B.
- Barclays fully exited Energy Transfer Partners, L.P. in Q4 2018, selling an estimated $184M.
- Barclays's ten largest holdings make up 32% of its $129B portfolio in Q4 2018.
- Barclays opened 489 new positions and closed 777 in Q4 2018.
- Barclays's portfolio value fell 10% quarter-over-quarter to $129B.
Based on Barclays's 13F filing for Q4 2018, filed 14 Feb 2019.